Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07356089Recruiting

Twiist Postmarket Surveillance Study for Type 1 Diabetes

Role: lead

NCT06853990Not ApplicableActive Not Recruiting

Innovative Automated Insulin Delivery System for Type 2 Diabetes

Role: lead

NCT04198012Not ApplicableCompleted

An Open Label Study to Allow Patients Continuous Use of the HemoCare™ Hemodialysis System

Role: lead

NCT04087213Not ApplicableCompleted

Study of HemoCare™ Hemodialysis System for Home Nocturnal Dialysis in Patients With ESRD

Role: lead

All 4 trials loaded